Previous studies documented racial and gender disparities in implantable cardioverter-defibrillator (ICD) placement. The authors examined whether racial and gender disparities in ICD placement are due to underutilization or overutilization. Among 1,054 adults hospitalized from 2001 to 2004 with ventricular arrhythmias in a large academic hospital, the study found that 17% of patients had clinical indicators concordant with ICD placement criteria. Among those, Blacks were less likely than Whites to receive an ICD (adjusted odds ratio [OR] = 0.24; 95% CI = 0.08-0.71). Among the 83% who were discordant with ICD placement criteria, Blacks (adjusted OR = 0.30; 95% CI = 0.18-0.52) and Hispanics (adjusted OR = 0.24, 95% CI = 0.10-0.57) were less likely than Whites, and women less likely than men, to receive an ICD (adjusted OR = 0.48; 95% CI = 0.34-0.67). In this cohort, these differences appear related to overutilization among men and Whites who are discordant with ICD placement criteria in addition to underutilization among Blacks concordant with placement criteria.
Agency for Healthcare Research and Quality. ( 2008). 2007 National Healthcare Disparities Report ( AHRQ Pub. No. 08-0041). Rockville, MD: U.S. Department of Health and Human Services.
2.
Alexander, M., Baker, L., Clark, C., McDonald, K.M., Rowell, R., Sayina, O., & Hlatky, M.A. ( 2002). Management of ventricular arrhythmias in diverse populations in California. American Heart Journal, 144, 431-439.
3.
The AVID Investigators. (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine, 337, 1576-1584.
4.
Ayanian, J.Z., Udvarhelyi, I.S., Gatsonis, C.A., Pashos, C.L., & Epstein, A.M. ( 1993). Racial differences in the use of revascularization procedures after coronary angiography. Journal of the American Medical Association, 269, 2642-2646.
5.
Bach, P.B., Pham, H.H., Schrag, D., Tate, R.C., & Hargraves, J.L. (2004). Primary care physicians who treat blacks and whites. New England Journal of Medicine , 351(6), 575-584.
6.
Bardy, G.H., Lee, K.L., Mark, D.B., Poole, J.E., Packer, D.L., Boineau, R., . . . John, H. ( 2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine , 352, 225-237.
7.
Curtis, L.H., Al-Khatib, S.M., Shea, A.M., Hammill, B.G., Hernandez, A.F., & Schulman, K.A. (2007). Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. Journal of the American Medical Association , 298(13), 1517-1524.
8.
Daubert, J.P., Zareba, W., Cannom, D.S., McNitt, S., Rosero, S.Z., Wang, P., . . . Moss, A.J. ( 2008). Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact . Journal of the American College of Cardiology, 51(14), 1357-1365.
9.
Daugherty, S.L., Peterson, P.N., Yongfei, W., Curtis, J.P., Heidenreich, P.A., Lindenfeld, J., . . . Masoudi, F.A. (2009). Use of implantable cardioverter defibrillators for primary prevention in the community: Do women and men equally meet trial enrollment criteria?American Heart Journal, 158(2), 224-229.
10.
Eckstein, J., Koller, M.T., Zabel, M., Kalusche, D., Schaer, B.A., Osswald, S., & Sticherling, C. (2008). Necessity for surgical revision of defibrillator leads implanted long-term: Causes and management . Circulation, 117(21), 2727-2733.
11.
Epstein, A.M., Ayanian, J.Z., Keogh, J.H., Noonan, S.J., Armistead, N., Cleary, P.D., . . . Conti, R.M. ( 2000). Racial disparities in access to renal transplantation: Clinically appropriate or due to underuse or overuse?New England Journal of Medicine, 343, 1537-1544.
12.
Epstein, A.M., Weissman, J.S., Schneider, E.C., Gatsonis, C., Leape, L.L., & Piana, R.N. ( 2003). Race and gender disparities in rates of cardiac revascularization: Do they reflect appropriate use of procedures or problems in quality of care ? Medical Care, 41, 1240-1255.
13.
Ezekowitz, J.A., Armstrong, P.W., & McAlister, F.A. (2003). Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Annals of Internal Medicine , 138(6), 445-452.
14.
Forrest, C.B., & Whelan, E.M. ( 2000). Primary care safety-net delivery sites in the United States: A comparison of community health centers, hospital outpatient departments, and physicians’ offices. Journal of the American Medical Association, 284, 2077-2083.
15.
Giacomini, M.K. ( 1996). Gender and ethnic differences in hospital-based procedure utilization in California. Archives of Internal Medicine, 156, 1217-1224.
16.
Gregoratos, G., Abrams, J., Epstein, A.E., Freedman, R.A., Hayes, D.L., & Hlatky, M.A. ( 2002). ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/NASPE Committee to Update the 1998 pacemaker guidelines). Circulation, 106, 2145-2161.
17.
Groeneveld, P.W., Heidenreich, P.A., & Garber, A.M. ( 2003). Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation, 108, 286-291.
18.
Groeneveld, P.W., Heidenreich, P.A., & Garber, A.M. ( 2005). Trends in implantable cardioverter-defibrillator racial disparity: The importance of geography. Journal of the American College of Cardiology, 45, 72-78.
19.
Guari, A.J., Davis, A., Hong, T., Burke, M.C., & Knight, B.P. ( 2006). Disparities in the use of primary prevention and defibrillator therapy among blacks and women. American Journal of Medicine , 119(2), e17-e21.
20.
Hernandez, A.F., Fonarrow, G.C., Liang, L., Al-Khatib, S.M., Curtis, L.H., LaBresh, K.A., . . . Peterson, E.D. (2007). Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. Journal of the American Medical Association , 298(13), 1525-1532.
21.
Institute of Medicine. (2001). Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academies Press.
22.
Jha, A.K., Fisher, E.S., Li, Z., Orav, E.J., & Epstein, A.M. ( 2005). Racial trends in the use of major procedures among the elderly. New England Journal of Medicine, 353(7), 683-691.
23.
McGuire, T.G., Alegria, M., Cook, B.L., Wells, K.B., & Zaslavsky, A.M. (2006). Implementing the Institute of Medicine definition of disparities: An application to mental health care . Health Services Research, 41(5), 1979-2005.
24.
Moss, A.J., Zareba, W., Hall, W.J., Klein, H., Wilber, D.J., Cannom, D.S., . . . Andrews, M.L. ( 2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346, 877-883.
25.
National Committee for Quality Assurance. ( 2008). The state of health care quality 2008. Washington, DC: Author.
26.
Norris, K., & Nissenson, A.R. (2008). Race, gender, and socioeconomic disparities in CKD in the United States. Journal of the American Society of Nephrology, 19(7), 1261-1270.
27.
Phurrough, S., Farrell, J., & Chin, J. ( 2003). Decision memorandum: Implantable cardioverter defibrillators (CAG 00157n). Baltimore, MD: Centers for Medicare and Medicaid Services. Retrieved from http://www.cms.hhs.gov/coverage/download/id39-5.pdf
28.
Rathore, S.S., Foody, J.M., Wang, Y., Smith, G.L., Herrin, J., & Masoudi, F.A. ( 2003). Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. Journal of the American Medical Association, 289, 2517-2524.
29.
Rathore, S.S., Foody, J.M., Wang, Y., Smith, G.L., Herrin, J., Masoudi, F.A. ( 2005). Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: Findings from the National Heart Failure Project. American Heart Journal, 149, 121-128.
30.
Redberg, R.F. ( 2007). Disparities in use of implantable cardioverter-defibrillators: Moving beyond process measures to outcomes data. Journal of the American Medical Association, 298(13), 1564-1566.
31.
Russo, A.M., Hafley, G.E., Lee, K.L., Stamato, N.J., Lehmann, M.H., Page, R.L., . . . Buxton, A.E. ( 2003). Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): A comparison of whites versus blacks. Circulation, 108, 67-72.
32.
Shekelle, P.G., Kahan, J.P., Bernstein, S.J., Leape, L.L., Kamberg, C.J., & Park, R.E. ( 1998). The reproducibility of a method to identify the overuse and underuse of medical procedures. New England Journal of Medicine, 338, 1888-1895.
33.
Smedley, B. D., Stith, A. Y., & Nelson, A. R. (Eds.). (2002). Unequal treatment: Confronting racial and ethnic disparities in health care. Washington, DC: Institute of Medicine, National Academies Press.
34.
Stevenson, L. ( 2006). Implantable cardioverter defibrillators for primary prevention of sudden death in heart failure: Are there enough bangs for the bucks. Circulation, 114, 101-103.
35.
Swindle, J., Burroughs, T.E., Schnitzler, M.A., & Hauptman, P.J. (2008). Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure. American Heart Journal, 156, 322-328.
36.
Vaccarino, V., Rathore, S.S., Wenger, N.K., Frederick, P.D., Abramson, J.L., Barron, H.V., . . . Krumholz, H.M. (2005). Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. New England Journal of Medicine, 353, 671-682.
